1. Home
  2. DMA vs INCR Comparison

DMA vs INCR Comparison

Compare DMA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Destra Multi-Alternative Fund

DMA

Destra Multi-Alternative Fund

SELL

Current Price

$7.30

Market Cap

67.0M

Sector

Finance

ML Signal

SELL

Logo Intercure Ltd.

INCR

Intercure Ltd.

N/A

Current Price

$4.95

Market Cap

58.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DMA
INCR
Founded
N/A
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.0M
58.6M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
DMA
INCR
Price
$7.30
$4.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 12.4K
3.8K
Earning Date
01-01-0001
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$200.38
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.94
$0.68
52 Week High
$9.15
$6.10

Technical Indicators

Market Signals
Indicator
DMA
INCR
Relative Strength Index (RSI) 30.50 45.35
Support Level $6.94 $0.81
Resistance Level $7.76 $5.58
Average True Range (ATR) 0.11 0.18
MACD -0.02 -0.15
Stochastic Oscillator 2.74 9.26

Price Performance

Historical Comparison
DMA
INCR

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income, with an emphasis on income generation. The Fund pursues its investment objective by investing mainly in the income-producing securities of real estate investment trusts (REITs) and alternative investment funds, as well as common stocks and structured notes, bonds, and asset-backed securities.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: